• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

World-Leading Veterinary Health Company Places Its First Order for a Liquid Nitrogen-Based Freezer From Reflect Scientific's Cryometrix Subsidiary

Posted on: Thursday, 29 May 2008, 06:00 CDT

Reflect Scientific, Inc. (OTCBB: RSCF) today announced that its wholly owned subsidiary, Cryometrix, has received an initial order for one of its T-150 Ultra-Low Temperature liquid nitrogen freezers from a world-leading veterinary health company.

Although this veterinary health company currently has more than 200 traditional mechanical freezers in use today to preserve manufactured products, none of these existing freezers operate on liquid nitrogen (LN2). In fact, the Cryometrix T-150 is the only commercially available upright LN2-powered ULT freezer on the market today.

"This client has a very large inventory of mechanical freezers which are in constant need of major repairs," said Dr. Boyd Bowdish, Director of Cryometrix. "The T-150 has a minimal number of moving parts, with no compressors or pumps, which dramatically minimizes freezer breakdown and the attendant costs of freezer repair and/or replacement. In addition, the T-150 liquid nitrogen freezer requires as little as one-tenth the electricity to operate, which is a huge cost savings.

"On top of that, T-150s occupy the same floor space as traditional mechanical ULT freezers, but have a capacity that is up to five times (5X) greater than these older freezers. When you add up all of these benefits together, it means that companies can replace their outdated, smaller capacity mechanical freezers with the newer, more effective and energy efficient T-150s and have a financial payback in literally just a few months.

"For example, some of our current customers find they can use the Cryometrix T-150 to blast-freeze massive quantities of desired product in one-sixth the time of their existing 'traditional' blast freezers. In total, the Cryometrix T-150 ULT LN2-powered freezer is without peer today. That's why this world-leading animal health company has placed its first order with us for a T-150."

Although Reflect Scientific and Cryometrix are not at liberty to divulge the identity of this animal health company, it has a distribution network covering more than 100 countries, generates more than $2 billion in annual revenue and is a division of a U.S.-based leading global health care company.

"This T-150 shipment marks a very interesting new avenue for Cryometrix and Reflect Scientific," said Kim Boyce, chairman and CEO of Reflect Scientific. "It's our first order into the animal health/veterinarian marketplace, which is a logical extension of our market penetration, so we're hopeful we'll see additional sales into this client and into other animal health companies in the future."

About Cryometrix

Cryometrix develops, manufactures and markets cryopreservation equipment. The Cryometrix Ultra-Low Temperature model T-150 freezer is an "all-in-one" cryogenic freezing system. It is the first liquid nitrogen-based (LN2), programmable cryogenic freezing system in a standard upright format, which allows for exceptional reliability, precise thermal uniformity and no user or product exposure to liquid nitrogen. The Cryometrix T-150 freezer is optimized for bio-repositories, research, forensic, hospital and clinical laboratories, and other life science applications where refrigeration and cryogenic preservation is required. Cryometrix is a wholly owned subsidiary of Reflect Scientific, Inc. For more information, go to www.cryometrix.com.

About Reflect Scientific, Inc.

Reflect Scientific, Inc. and its subsidiaries provide products for life science, biotechnology and pharmaceutical industries, as well as tools and analytical services for industrial manufacturing. For more information, visit www.reflectscientific.com.

Cautionary Note Regarding Forward-Looking Statements:

Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, continued acceptance of the company's products, increased levels of competition for the company, new products and technological changes, the company's dependence on third-party suppliers, and other risks detailed from time to time in the company's periodic reports filed with the Securities and Exchange Commission.

Source: Business Wire

More News in this Category